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Transient receptor potential melastatin 2 (TRPM2) is a calcium permeable non-selective cation channel that functions as
a sensor of cellular redox status. Highly expressed within the CNS, we have previously demonstrated the functional
expression of these channels in CA1 pyramidal neurons of the hippocampus. Although implicated in oxidative stress-
induced neuronal cell death, and potentially in neurodegenerative disease, the physiological role of TRPM2 in the central
nervous system is unknown. Interestingly, we have shown that the activation of these channels may be sensitized by
co-incident NMDA receptor activation, suggesting a potential contribution of TRPM2 to synaptic transmission. Using
hippocampal cultures and slices from TRPM2 null mice we demonstrate that the loss of these channels selectively
impairs NMDAR-dependent long-term depression (LTD) while sparing long-term potentiation. Impaired LTD resulted from
an inhibition of GSK-3b, through increased phosphorylation, and a reduction in the expression of PSD95 and AMPARs.
Notably, LTD could be rescued in TRPM2 null mice by recruitment of GSK-3b signaling following dopamine D2 receptor
stimulation. We propose that TRPM2 channels play a key role in hippocampal synaptic plasticity.
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Background
The transient receptor potential melastatin 2 channel
(TRPM2) is a novel non-selective cation channel that
was initially cloned from the brain, and was subse-
quently identified as an effector of calcium fluxes fol-
lowing oxidative stress[1]. Functionally, TRPM2 has
been linked to cell death, cytokine production, and insu-
lin secretion[1]. Interestingly, TRPM2 expression is
greatest in the central nervous system (CNS) where it
may contribute to neurodegenerative disease[1,2]. We
recently demonstrated functional expression of TRPM2
in CA1 pyramidal neurons[3], in culture and in situ.
TRPM2 is unique among known ion channels in that it
contains a cryptic C-terminal enzyme domain homolo-
gous to the NUDT9 ADP-ribose (ADPR) hydrolase.
This channel motif serves primarily as the ligand
binding domain for ADPR, which is required for Ca
2
+-dependent gating of the channel[4]. In hippocampal
neurons, TRPM2 currents can be activated by voltage-
ramps that generate inward Ca
2+ currents or by strong
stimulation of NMDA receptors (NMDARs)[3]. Indeed,
high concentrations of ADPR are unable to evoke these
currents until activated by an influx of Ca
2+. The cou-
pling of channel activity to Ca
2+ signaling downstream
of voltage-gated Ca
2+ channels and NMDARs suggests
that TRPM2 could play a role in neuronal signaling or
synaptic transmission. Given the lack of selective
antagonists, we have examined the hypothesis that these
channels contribute to synap t i cp l a s t i c i t yb ye m p l o y i n g
TRPM2 deficient mice[5].
Results
Hippocampal neurons were cultured from wildtype
(WT) and knockout (TRPM2
-/-)m i c eu s i n gs t a n d a r d
procedures outlined in the methods. This allowed us to
compare the activation of TRPM2 currents in cultured
pyramidal neurons from both genotypes. Whole-cell
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ADPR in the patch solution. Under these recording con-
ditions TRPM2 currents were absent until multiple vol-
tage-ramps are used to evoke these slowly developing
currents. Large TRPM2 inward currents were generated
at a holding potential of -60 mV in neurons from WT
mice (Figure 1a,c; 553.4 ± 132 pA, n = 5) but were
entirely absent in those from TRPM2
-/- mice (Figure 1b,
c ;7 . 9±7 . 2p A ,n=6 ;u n p a i r e dt - t e s t ,p =0 . 0 0 1 ) .
Importantly, no genotypic difference in peak Ca
2+ cur-
rents were detected (3648 ± 715 pA in WT, 2836 ± 390
pA in KO; unpaired t-test, p=0.3234; data not shown).
Furthermore, there were no changes in peak responses
(or steady-state to peak ratios) to applications of NMDA
(Figure 2a,b) or in the GluN2Bmediated component of
this response determined by application of 1 μM Ro 25-
6981, a highly selective antagonist of GluN2B containing
receptors (Figure 2c-e). These results confirm the func-
tional identification of TRPM2 currents in hippocampal
pyramidal neurons, the absence of TRPM2 currents in
n e u r o n sc u l t u r e df r o mT R P M 2d e f i c i e n tm i c e ,a n dt h a t
the absence of TRPM2 does not alter either voltage-
dependent or NMDAR-dependent Ca
2+ currents.
Next, acute transverse hippocampal slices were pre-
pared from TRPM2
-/- and WT mice at 3-4 weeks of age
using standard approaches described in the methods.
Figure 1 LTD is impaired in hippocampal slices derived from TRPM2
-/- mice. (a,b) ADPR-primed TRPM2 currents are facilitated by voltage
ramps ( ± 100 mV, 1/10 sec) in WT (a), but not in cultured neurons from TRPM2
-/- mice (b). (c) Summary bar graph of ADPR-primed peak
current amplitude in WT and TRPM2
-/- neurons. (unpaired t-test p=0.001, 553.4 ± 132 pA in WT, n = 5; 7.9 ± 7.2 pA in KO, n = 6) (d) Transient
oxygen-glucose deprivation (5 min OGD) causes long-lasting depression of fEPSP slopes in slices from WT (n = 12) but not TRPM2
-/- (n = 6). (e)
LTP is unaffected by knockout of TRPM2 (WT, n = 6; TRPM2
-/-, n = 8). (f) LTD of fEPSPs evoked by repetitive stimulation (900 stimuli at 1 Hz) in
WT slices (n = 10) is absent in slices from TRPM2
-/- mice (n = 10). (g) LTD of fEPSPs was inhibited by application of clotrimazole, a TRPM2
inhibitor. Timing of clotrimazole application, in treated slices, is indicated by the black bar. (h) Metabotropic-glutamate receptor dependent LTD
is unimpaired by deletion of TRPM2 (WT, n = 6; TRPM2
-/-, n = 7). (i) Chem-LTD, evoked by 5 min application of NMDA (10 μM) is abolished in
slices from TRPM2
-/- (n = 6) but not WT (n = 6) slices. (j) Summary graph for a series of recordings from WT and TRPM2
-/- slices in which
plasticity was induced by repetitive stimulation delivered at 1, 10, 20, 50 Hz (900 pulses at each frequency) or 100 Hz (four 1 sec trains delivered
20 sec apart). For each induction frequency, normalized fEPSP slopes, measured at the end of recording from each of the two populations of
slices, are plotted. Numbers in parentheses represents the number of recordings at each point. *denotes p = 0.016.
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recorded from CA3-CA1. We noted no difference in the
paired-pulse ratios between WT and TRPM2
-/- mice
(additional file 1). We then examined the effects of a
short period of oxygen-glucose deprivation (OGD) on
fEPSPs in slices from both genotypes. In WT slices,
OGD resulted in a strong depression of the fEPSPs.
This depression was greatly diminished in TRPM2
-/-
Figure 2 NMDAR function is unaffected by disruption of TRPM2 channel expression. Neither peak (a) nor steady-state/peak (b) currents,
generated in response to rapid applications of NMDA to cultured hippocampal neurons, are affected by loss of TRPM2 expression. Similarly, the
sensitivity of NMDA-evoked responses (peak amplitude (c), total charge transfer (d) and representative traces (e) recorded from cultured
hippocampal neurons, to inhibition by the GluN2B specific antagonist, Ro 25-6981, is unaltered in neurons from TRPM2
-/-. (f) Inhibition of
pharmacologically isolated NMDAR-mediated synaptic currents, recorded from CA1 pyramidal neurons in response to Schaffer-collateral
stimulation, by Ro 25-6981 is unaltered in slices from TRPM2
-/-. For all results presented in panels a-d, n = 5; for panel f, WT: n = 6; TRPM2
-/-: n =5 )
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siveness to the oxidative stress mediated by TRPM2
channels (Figure 1d).
Given that TRPM2 currents can be activated by
NMDAR stimulation we examined whether TRPM2
might contribute to NMDAR-dependent synaptic plasti-
city. We first examined the induction of long-term
potentiation (LTP) using a standard 100 Hz stimulation.
No difference in LTP was observed in slices from
TRPM2
-/- mice (Figure 1e) suggesting that TRPM2 plays
little or no role in this form of synaptic plasticity. How-
ever, NMDARs are also required for one form of long-
term depression (LTD) at these synapses so we extended
our studies to include low frequency stimulation.
Applying 900 pulses at 1 Hz induced LTD in WT
mice (0.84 ± 0.021, n =1 0 )b u tf a i l e dt od os oi n
TRPM2
-/- mice (Figure 1f; 0.98 ± 0.025, n = 10; p =
0.017). Acute applications of the TRPM2 blocker clotri-
mazole also blocked LTD induced using this protocol
(Figure 1g). Clotrimazole did not inhibit the induction
of LTP (data not shown). LTD at these synapses can
also depend upon activation of group 1 mGluRs rather
than NMDARs[6], we therefore examined responses to a
bath exposure to NMDA (10 μM, 5 min) or DHPG (10
μM, 20 min) in slices of both genotypes. The LTD
induced by DHPG was similar in WT and TRPM2
-/-
mice (Figure 1h; 0.85 ± 0.043, n = 6 in WT vs 0.80 ±
0.031, n = 7 in TRPM2
-/- mice, respectively; p > 0.05).
Conversely, NMDA application induced LTD in slices
from WT (n = 6) but failed to do so TRPM2
-/- mice
(Figure 1i; n = 6). When plasticity induced by a range of
repetitive stimulation frequencies was examined it was
clear that TRPM2
-/- slices demonstrated a substantial
impairment in NMDA-dependent LTD (Figure 1j).
The expression of NMDAR-dependent LTD at CA3-
CA1 synapses requires the endocytosis of AMPA Recep-
tors (AMPARs)[6,7]. To determine if there was a change
in the functional expression of AMPARs in TRPM2
-/-
mice we used whole cell voltage clamp recordings to
measure the ratio of AMPAR to NMDAR mediated
EPSCs. By holding the membrane potential at -70 and
+40 mV the relative contribution of each receptor type
was determined. This ratio was significantly reduced in
TRPM2
-/- (n = 10) neurons compared to WT (n = 10, p
< 0.01; Figure 3a). These results suggest that a reduction
of synaptic AMPARs or alternatively an enhancement of
N M D A R sm a yu n d e r l i et h ed e f i c i e n c yo fL T Di n
TRPM2
-/-mice. A change in AMPARs was supported by
our observation of a reduction of mEPSC amplitude but
not frequency in TRPM2
-/- mice (Figure 3b,c). We also
examined the relative contribution of NMDARs com-
posed of GluN2A or GluN2B subunits to synaptic cur-
rents by measuring EPSCNMDAR before and after
application of the selective GluN2B antagonist, Ro 25-
6981. The relative block was the same regardless of gen-
otype (Figure 2f).
During LTD there is some loss of postsynaptic density
95 protein (PSD-95) from the synapses followed by
endocytosis of AMPAR[8]. Therefore, we used western
blotting to examine if there was a change in PSD-95
expression in TRPM2
-/- mice. Consistent with the
change in AMPARs, we observed a significant reduction
in PSD-95 expression (Figure 3d). Previous reports link
the level of PSD-95 expression with AMPAR number
without an overall change in synaptic number[8,9]. We
examined the total expression of GluR1 in TRPM2
-/-
slices versus those from WT mice, and as anticipated
observed a reduction in the expression of GluR1 (Figure
3e). In contrast, the expression levels of GluR2 and
NMDAR subunits were the same regardless of genotype
(Figure 4a,b).
To further explore the mechanism of the loss of
NMDAR-dependent LTD in TRPM2
-/- mice we exam-
ined the activity of glycogen synthase kinase-3b (GSK-
3b), which is required for this form of LTD[10,11]. We
compared the expression levels as well as the phosphor-
ylation of this kinase at Ser9, which is indicative of inac-
tivation of GSK-3b[12]. Although the expression of
GSK-3b was unaltered, there was a significant increase
in Ser9 phosphorylation (GSK-3b inactivation) in
TRPM2
-/- slices (Figure 3f) suggesting that impaired
LTD in TRPM2
-/- mice results from inhibition of GSK-
3b[10]. Insulin also acts via stimulation of Akt/PKB to
inactivate GSK-3b via Ser9 phosphorylation, resulting in
a long lasting depression of AMPAR-mediated synaptic
transmission, which in turn occludes low frequency
induced LTD[13]. We therefore examined the effect of
insulin on wildtype and TRPM2
-/- slices. The long-last-
ing depression induced by applications of insulin was
lacking in TRPM2
-/- slices (Figure 3g) suggesting that
insulin-induced LTD was occluded in this genotype due
to the pre-existing inactivation of GSK-3b. To determine
if the loss of LTD in TRPM2
-/- was attributable to the
consistent inhibition of GSK-3b we applied the D2 ago-
nist, quinpirole in order to stimulate Akt GSK-3b signal-
ing[14] and observed an enhanced activation of GSK-3b




Our results show that loss of TRPM2 expression modi-
fies NMDAR-dependent synaptic plasticity, specifically
LTD, but they do not implicate TRPM2 channels
directly in excitatory synaptic transmission. Instead, the
presence of TRPM2 channels is associated with mainte-
nance of the appropriate level of GSK-3b activation as
well as full expression PSD-95 and AMPARs. In the
a b s e n c eo ft h eT R P M 2e x p r e s s i o nt h e r ei sar e d u c t i o n
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mice. (a) The ratio of AMPAR- to NMDAR-mediated EPSCs is reduced in TRPM2
-/- neurons. (b,c) The amplitude, but not the frequency, of
mEPSCs is reduced in slices from TRPM2
-/- mice. Representative traces of mEPSCs recordings from slices derived from WT and TRPM2
-/- mice are
shown. The expression of (d) PSD-95 (normalized to b-actin loading control) and (e) of the AMPAR subunit, GluR1, is depressed in slices from
TRPM2
-/- mice. (f) Knockout of TRPM2 causes increased phosphorylation of GSK-3b, at its inhibitory site (Ser9, n = 3). (g) Insulin application to
hippocampal slices depresses AMPAR-mediated fEPSPs in slices from TRPM2
-/-, but not WT, slices. (h) Simulation of dopamine D2 receptors by
quinpirole (10 μM) reduces GSK-3b phosphorylation at Ser9 (n = 3). (i) D2 receptor stimulation by quinpirole rescues LTD in slices from TRPM2
-/-
mice.
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synaptic transmission at CA1 synapses along with a
reduction of LTD and a shift to lower thresholds for the
induction of LTP. This metaplastic shift towards LTP in
TRPM2
-/- slices results from enhanced phosphorylation
and inactivation of GSK-3b. The resulting inactivation
of GSK-3b prevented further depression of synaptic
transmission by applications of insulin. Importantly,
applications of quinpirole reduced GSK-3b phosphoryla-
tion in TRPM2
-/- slices and effectively rescued LTD
induction by repetitive low-frequency stimulation. More-
over, acute block of TRPM2 function by clotrimazole
prevented LTD induction thereby mimicking TRPM2
loss of function by genetic deletion. Collectively, these
findings argue that the reductions in GSK-3b activity,
PSD-95 and GluR1 expression, as well as AMPAR-
mediated synaptic transmission and plasticity observed
in hippocampal slices derived from TRPM2
-/- mice can-
not simply be attributed to developmental compensa-
tions resulting from genetic deletion of TRPM2. Rather,
in light of our findings, we propose that ongoing
TRPM2 channel activity contributes to the regulation
AMPAR-mediated fast excitatory synaptic transmission
through maintenance of constitutive GSK-3b activity.
The precise mechanism through which TRPM2 activ-
ity regulates GSK-3b remains to be determined; however
the contribution of TRPM2 to Ca
2+ signaling is likely to
play an important role is this regard. Previous findings
have proposed the Ca
2+-dependent phosphatase, calci-
neurin (or PP2B), as a candidate for mediating depho-
sphorylation of GSK-3b at Ser9[15]. Alternatively, the
Ca
2+-dependent tyrosine kinase Pyk2 has been shown to
associate and regulate GSK-3b activity through tyrosine
phosphorylation[16]. Whether the activity of either cal-
cineurin, Pyk2, or other kinases or phosphatases are
altered by TRPM2-initiated Ca
2+ signaling remains to be
established. Similarly, the behavioural consequence of
altered synaptic transmission and plasticity associated
with the loss of TRPM2 function has yet to be investi-
gated; however, a recent paper by Kim and colleagues
(2011) may offer some insight. These authors demon-
strated that behavioural flexibility, evaluated by reversal
learning in the Morris water maze and by the delayed
non-match to place T-maze task, was reduced following
genetic disruption of PI3Kg, which also resulted in a
selective loss of NMDAR dependent LTD [17]. Addi-
tional research is required to assess whether these beha-
viours are similarly altered in TRPM2
-/- mice.
Figure 4 Comparison of glutamate receptor subunit expression in hippocampal slices derived from WT and TRPM2
-/- mice. (a) Western
blots and summary bar graph representing the expression levels of the AMPA receptor subunit subtypes, GluR1 and GluR2. Note that the
quantified data for GluR1 is the same as that presented in Figure 2. (b) Western blots and summary bar graph representing the expression levels
of the NMDA receptor subunit subtypes, GluN1 (n = 3), GluN2A (n = 5) and GluN2B (n = 3).
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The present study establishes that loss of TRPM2 func-
tion through genetic means provokes long lasting
changes in excitatory synaptic transmission and plasticity
at the CA3-CA1 hippocampal synapse. Specifically, we
show that the ability to induce NMDAR-dependent LTD
is impaired in TRPM2
-/- mice. Such impairment was
associated with increased phosphorylation and inactiva-
tion of GSK-3b. Consistent with previously reported
changes associated with GSK-3b inhibition, we report
reduced PSD95 and GluR1 expression and identify a cor-
responding reduction in AMPAR-mediated synaptic
transmission. Interestingly, both GSK-3b and TRPM2
channels have been implicated in a number of overlap-
ping pathophysiological processes ranging from pancrea-
tic insulin secretion to Alzheimer’s disease[1,18].
Accordingly, our results show the importance of continu-
ing studies to determine the pathophysiological roles of
GSK-3b and TRPM2 in neurodegenerative diseases[19].
Methods Experimental animals
TRPM2
-/- mice, generated as described previously[5],
were provided by Dr Y Mori. Wild-type and KO mice
used for experimentation were derived from heterozy-
gous matings and mouse genotyping was performed as
previously described[5]. Mice were kept in a pathogen-
free environment, and analyses were performed using
mice that were matched for age. All animal experiments
were performed in accordance with protocols approved
b yt h eU n i v e r s i t yo fW e s t e r nO n t a r i oA n i m a lU s eS u b -
committee of the University Council on Animal Care.
Whole-cell recording from primary culture
Mouse hippocampal primary neuronal cultures were
prepared from timed-pregnant TRPM2
-/- or WT mice
according to previously described procedures[20]. Cur-
rents were recorded from 21-28 days in vitro. Whole-
cell voltage-clamp recordings were performed as
described previously[3], with minor adjustments. Briefly,
standard intracellular solution (ICS) contained (in mM):
150 cesium gluconate, 10 Hepes, and 2 MgCl2. To
record NMDA currents, 11 mM EGTA, 1 mM CaCl2,
and 2 mM K2-ATP was added to the ICS. TRPM2 cur-
rents were recorded with 1 mM ADPR added to the
ICS. Standard extracellular solution (ECS) contained (in
mM): 140 NaCl, 5.4 KCl, 25 Hepes, 33 glucose, 2 CaCl2,
and 0.2 μM TTX. To generate NMDA currents, 50 μM
NMDA and 0.5 μM glycine was added to the standard
ECS and applied for 3 seconds every minute using a
multibarrelled rapid perfusion system (SF77B; Warner
Instruments). For experiments examining the contribu-
tion of GluN2B receptor, 1 μM Ro 25-6981 (Tocris) was
applied after having obtained 3 stable control sweeps in
its absence. ADPR-primed TRPM2 currents were gener-
ated with voltage ramps ( ± 100 mV, 1/10 sec) applied
in the presence of standard ECS supplemented with 1
mM MgCl2 and 1 mM BaCl2. After the TRPM2 current
stabilized, or after 10 minutes of voltage ramps, cal-
cium-free solution was applied (total divalent concentra-
tion maintained by replacing CaCl2 with equimolar
BaCl2). Voltage-clamp recordings (Vhold = -60 mV)
were performed at room temperature (20-22°C) using a
Multiclamp 700A amplifier (Molecular Devices). Data
were filtered at 2 kHz, digitized, and acquired using
pCLAMP and Axoscope software (Molecular Devices).
Hippocampal slices preparation
Hippocampal slices were prepared from age-matched
TRPM2
-/- and wild type mice (post-natal day 20-30).
Briefly, mice were decapitated after isoflurane anesthe-
sia, and brains were quickly removed and placed in ice-
cold oxygenated (95% O2,5 %C O 2) artificial CSF
(ACSF) containing: 124 mM NaCl, 3 mM KCl, 1.25 mM
NaH2PO4, 1.3 mM MgCl2, 2.6 mM CaCl2, 26 mM
NaHCO3 and 10 mM glucose (osmolality between 300
and 310 mOsm). Whole-brain coronal slices (300 μm)
containing transverse sections of the hippocampus were
prepared using a vibrating microtome (VT100E; Leica).
After a recovery period of 1 h in oxygenated ACSF, hip-
pocampal slices were transferred to a recording chamber
continuously perfused with oxygenated ACSF (3 ml/
min), warmed to 31°C through an in-line solution
heater.
Field excitatory postsynaptic potentials (fEPSP) recording
from Schaffer collateral-CA1 synapses
fEPSPs were evoked every 30 s (0.033 Hz) by electrical
stimulation (100 μs duration) delivered to the Schaffer-
collateral pathway using a concentric bipolar stimulating
electrode (25 μm exposed tip) and recorded using glass
microelectrodes (3-5 MΩ, filled with ACSF) positioned
in the stratum radiatum of the CA1 area. The stimuli
intensity was adjusted to evoke fEPSPs corresponding to
30~50% of the maximal response evoked in the absence
of a contaminating spike discharge. The paired-pulse
ratio was determined in each slice by delivering pairs of
stimuli at varying interstimulus intervals (10-1000 ms).
For LTD/LTP experiments, baseline fEPSPs were moni-
tored for at least 20 min to ensure stability, following
which synaptic plasticity was induced by repetitive sti-
mulation delivered at 1, 10, 20, 50 Hz (900 pulses at
each frequency) or 100 Hz (four 1 sec trains delivered
20 sec apart). Following repetitive stimulation, fEPSP
slopes were monitored for 1 h. Signals were amplified
(Axoclamp 700B, Molecular Devices, recorded digitally
(Digidata 1440A) and analyzed offline using Clampfit 10.
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slices
Visual patch recordings from CA1 pyramidal neurons
were performed using the whole-cell configuration with
holding potential at -60 mV. Patch pipettes, pulled from
borosilicate glass (4-6 MΩ), were filled with an internal
solution containing (in mM): Cs-gluconate 132.5, CsCl
17.5, HEPES 10, EGTA 0.2, Mg-ATP 2 and GTP 0.3 (pH
7.25, 290 mOsm). Synaptic responses were evoked with a
concentric bipolar tungsten electrode located about 50
μm from the cell body layer in CA1. In some recordings,
NMDAR-mediated EPSCs werep h a r m a c o l o g yi s o l a t e d
by supplementing our aCSF with CNQX (10 μM). The
AMPAR- and NMDAR-mediated EPSCs were measured
at -70 mV and +40 mV, respectively. For NMDAR-
EPSCs, the amplitude was measured 20 ms after the start
of the stimulus artifact[21]. Signals were amplified using
multiclamp 700B, sampled at 5 kHz, and analyzed with
Clampfit 10 software (Molecular Devices).
Western Blotting
For the basal protein expression and protein phosphoryla-
tion assays, hippocampal tissue from wild type and
TRPM2
-/- mice (post-natal day 20-30) was used for Wes-
tern blot. For experiments involving quinpirole treatment,
hippocampal slices were incubated in ECS solution
bubbled with 95%O2 and 5%CO2 at room temperature for
at least 1 h, followed by exposing to quinpirole (10 μM) or
vehicle for 30 min in aCSF. After 3 times wash with cold
PBS, hippocampal tissue was homogenized in ice-cold
RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1
mM EDTA, 0.1% SDS, 0.5% Triton-X100, and 1% Sodium
Deoxycholate) containing protease and phosphatase inhi-
bitors. These samples were subjected to SDS-PAGE, trans-
ferred to a nitrocellulose membrane, which was then
subjected to repeated stripping and successive probing
with antibodies, as described. The signals were quantified
using VersaDoc Imaging System (BioRad). The antibodies
PSD95, pGSK3b
Ser9, GSK3b, NR2A and NR2B were pur-
chased from Cell Signaling Technology, and GluR1 and
GluR2 from Santa Cruz Biotechnology, Inc.
Statistics
Data are expressed as mean ± SEM. Statistical compari-
sons were made using either unpaired t-test or one-way
ANOVA followed by Bonferroni post-hoc test, depend-
ing on the experimental protocol.
Additional material
Additional Files 1: Short-term plasticity of excitatory synaptic
transmission is unaltered in slices from TRPM2
-/-. Summary graph (a)
and representative traces (b). Only a subset of interstimulus intervals are
shown from a series recordings from WT (n = 11) and TRPM2
-/- (n = 11)
slices. The time course for recovery from paired-pulse facilitation was
identical in slices derived from WT and TRPM2
-/- mice.
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